Search

everythinglearnresearchcommunity

for

Search:↓

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Apple polyphenols, especially from unripe apples, can help prevent cells from turning into fat cells.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Metformin can help diagnose and treat high testosterone levels in women, often due to insulin resistance rather than a tumor.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Vitisin A reduces triglycerides better than Cyanidin-3-O-glucoside.

Sonidegib often causes hair loss, and LC-OCT helps identify early signs.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.